Pamela Driol

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

Marta Bonotto, Lorenzo Gerratana, Elena Poletto et al. · The Oncologist · 2014 · 283 citations · Full text

Factors affecting patient's perception of anticancer treatments side-effects: an observational study

Stefania Russo, M. Cinausero, Lorenzo Gerratana et al. · Expert Opinion on Drug Safety · 2013 · 39 citations

A Double-blind, Randomized Phase lib Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared to Placebo (PL) When Administered in Combination with Docetaxel And/or Letrozole in Patients with Metastatic Breast Cancer (MBC): FM-B07-01 Trial

Gabriella Mariani, Olga Burdaeva, Luís San Román et al. · European Journal of Cancer · 2011 · 22 citations

Metastatic Breast Cancer, Oncology, Fm-b07-01 Trial +10

Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy

Manuela Miscoria, Fabrizio Tonetto, Laura Deroma et al. · Anti-Cancer Drugs · 2011 · 16 citations

Prognostic Factors, Advanced Breast Cancer, Breast Oncology +14

Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma

Alessandro Marco Minisini, Gaetano Pascoletti, Donatella Intersimone et al. · Melanoma Research · 2013 · 15 citations

Melanoma Cell Lines, Malignant Disease, Medicine +14